UK faces medicine shortages after no deal: leaked govt report
21-08-2019
Pharma bodies sign NDAs with UK govt over no-deal Brexit plans
16-08-2019
ratlos / Shutterstock.com
Leaving the EU without a deal in place could “irreparably” harm the UK’s National Health Service (NHS) and lead to delays in new products being bought to market in the country, according to the British Medical Association (BMA).
You need a subscription to continue reading this content.
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
Brexit, no deal Brexit, BMA, medical supplies, drug shortages, drug stockpiling, EMA, MHRA, Chaand Nagpaul
